BOTOX® Prophylaxis in Patients With Chronic Migraine

Study Identifier
191622-110
CT.gov Identifier
NCT01432379
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Migraine - General
    • Study Drug
  • botulinum toxin Type A
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of chronic migraine * Willing to use BOTOX® as preventative treatment for migraine
    Exclusion Criteria:
    * None

    Protocol Summary

    This is a post authorization observational study to monitor the utilization practices and describe the safety profile of BOTOX® in clinical practice for the prophylactic treatment of headaches in adult patients with chronic migraine.

    Study Locations

    Location
    Status
    Location
    Munich, Germany
    Status
    Not applicable
    Location
    Oviedo, Spain
    Status
    Not applicable
    Location
    Stockholm, Sweden
    Status
    Not applicable
    Location
    London, United Kingdom
    Status
    Not applicable